DE60141590D1 - Rmodells - Google Patents

Rmodells

Info

Publication number
DE60141590D1
DE60141590D1 DE60141590T DE60141590T DE60141590D1 DE 60141590 D1 DE60141590 D1 DE 60141590D1 DE 60141590 T DE60141590 T DE 60141590T DE 60141590 T DE60141590 T DE 60141590T DE 60141590 D1 DE60141590 D1 DE 60141590D1
Authority
DE
Germany
Prior art keywords
heart failure
stenosis
human mammal
coronary
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60141590T
Other languages
English (en)
Inventor
Shuji Fujiwara
Shota Ikeda
Keiji Kusumoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60141590D1 publication Critical patent/DE60141590D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Disintegrating Or Milling (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
DE60141590T 2000-09-27 2001-09-27 Rmodells Expired - Lifetime DE60141590D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000294988 2000-09-27
PCT/JP2001/008418 WO2002026031A1 (fr) 2000-09-27 2001-09-27 Procede d'obtention d'un animal souffrant d'insuffisance cardiaque

Publications (1)

Publication Number Publication Date
DE60141590D1 true DE60141590D1 (de) 2010-04-29

Family

ID=18777487

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60141590T Expired - Lifetime DE60141590D1 (de) 2000-09-27 2001-09-27 Rmodells

Country Status (6)

Country Link
US (1) US7166762B2 (de)
EP (1) EP1321032B1 (de)
AT (1) ATE460837T1 (de)
AU (1) AU2001290288A1 (de)
DE (1) DE60141590D1 (de)
WO (1) WO2002026031A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006030737A1 (ja) * 2004-09-13 2006-03-23 Japan Health Sciences Foundation 動脈閉塞性疾病モデル動物の作製
US20090263324A1 (en) * 2005-10-28 2009-10-22 Atsushi Sugiyama Animal Model With Induced Arrhythmia
CN107273655B (zh) * 2017-05-10 2020-07-14 大连理工大学 一种人体心室肌组织的心力衰竭模型的设计方法

Also Published As

Publication number Publication date
US20040006781A1 (en) 2004-01-08
US7166762B2 (en) 2007-01-23
EP1321032A4 (de) 2005-01-19
EP1321032B1 (de) 2010-03-17
ATE460837T1 (de) 2010-04-15
AU2001290288A1 (en) 2002-04-08
WO2002026031A1 (fr) 2002-04-04
EP1321032A1 (de) 2003-06-25

Similar Documents

Publication Publication Date Title
ATE206757T1 (de) Thrombin sowie verfahren zu seiner herstellung
ATE555782T1 (de) Prävention und/oder behandlung von kardiovaskulären erkrankungen und/oder damit zusammenhängender herzinsuffizienz
DE60312309D1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
SE436739C (sv) Forfarande for att vid behandling av avloppsvatten medelst en aktivslammetod forhindra produktion av trad- eller fiberartad biomassa
ATE129644T1 (de) System zur verabreichung von einem, eine übung simulierenden medikaments im geschlossenen kreislauf.
SE0202347D0 (sv) A heart monitoring device, a system including such a device and use of the system
NO20023879L (no) Partielle fettsyre-oksydasjonsinhibitorer i behandlingen av kongestiv hjertesvikt
TW200602031A (en) Antiinflammatory and pain-relieving agent for external, use
NO20076121L (no) Behandlinger for kardiovaskulaer sykdom
NO941485L (no) Fremgangsmåte for in vivo måling av konsentrasjonen av NMR-påviselig xenobiotisk forbindelse
WO2002032435A3 (en) A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
CY1110881T1 (el) Παραγωγα κιναζολινης χρησιμα στη θεραπεια περιφερικης αρτηριακης νοσου και ως αναστολεις της φωσφοδιεστερασης
DE60141590D1 (de) Rmodells
ATE10156T1 (de) An elementen reiche zusammensetzung.
ATE422886T1 (de) Neue heterocyclische analoge von diphenylethylenverbindungen
DK452089D0 (da) Anvendelse af ace-inhibitorer
ATE216888T1 (de) Desferri-exochelin zur behandlung von atherosclerose und gefässbeschädigung durch verhinderung der proliferation von glatten muskelzellen
NO20023111D0 (no) Utvortes preparat for behandling av pruritus
ATE520407T1 (de) Verwendung von corrinoiden zur anwendung bei hauterkrankungen
ES2174144T3 (es) Anticuerpos contra el factor de crecimiento derivado de plaquetas en el tratamiento de la reestenosis.
DE69519599D1 (de) Verwendung von gegen Abbau im Pancen von Wiederkäuern geschützten Wirkstoffen als Hepatoprotektor
ATE345121T1 (de) Verwendung von konjugierter linolsäure zur behandlung der erkältung
DE602004028621D1 (de) Gefässimplantat
PA8510601A1 (es) Eteres de dicarboxilato de calcio, metodos para su preparacion y tratamiento de las enfermedades vasculares y diabetes con los mismos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition